Skip to main content
Equibles

Tower Research Capital LLC (TRC)

Position in TLRY — Tilray Brands, Inc.

CIK 1533421 NEW YORK, NY
Back to TLRY Full portfolio

Position in TLRY

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$70,209
+$61,792 QoQ
Shares Held
15,637
+1101.9% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 235 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TLRY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $14,082,412 across 58 Drug Manufacturers - Specialty & Generic names. TLRY ranks #25 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HIMS
Hims & Hers Health, Inc.
 111,351 $3,860,538
2 UTHR
UNITED THERAPEUTICS Corp
 3,880 $2,102,300
3 ZTS
Zoetis Inc.
 24,069 $1,729,598
4 NBIX
Neurocrine Biosciences Inc
 7,270 $1,225,285
5 ELAN
Elanco Animal Health Inc
 38,301 $942,587
6 LNTH
Lantheus Holdings, Inc.
 6,773 $751,395
7 ALKS
Alkermes plc.
 6,157 $322,626
8 INDV
Indivior Pharmaceuticals, Inc.
 7,032 $288,522

All Filings in TLRY

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $70,209 15,637
2026-03-31 $8,417 1,301
2025-12-31 $123,602 13,688
2025-09-30 $31,767 18,363
2025-06-30 $5,269 12,852
2025-03-31 $9,603 14,551
2024-12-31 $42,393 31,875
2024-09-30 $36,168 20,550
2024-06-30 $52,587 31,679
2024-03-31 $112,964 45,735
2023-12-31 $184,234 80,102
2023-09-30 $222,625 93,149
2023-06-30 $110,395 70,767
2023-03-31 $34,364 13,583
2022-12-31 $103,609 38,517
2022-09-30 $111,317 40,479
2022-06-30 $230,267 73,804
2022-03-31 $404,506 52,060
2021-12-31 $170,160 24,205
2021-09-30 $275,351 24,389
2021-06-30 $912,931 50,494
2021-03-31 $3,926,698 172,754
2020-12-31 $2,478 300
2020-09-30 $44,862 9,250
2020-06-30 $7,479 1,052
2020-03-31 $53,423 7,765